Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Report: Regulatory Update, Long-Chain Omega-3 EPA and DHA Fatty Acids
When it comes to recognizing the potential health benefits of omega-3 fatty acids, different regions of the world have taken unique regulatory approaches.
August 27, 2015
1 Min Read
Report Summary
When it comes to recognizing the potential health benefits of omega-3 fatty acids, different regions of the world have taken unique regulatory approaches.
Editor's Take
Compared to other geographies, the United States has not been as progressive in or supportive of realizing the public health benefits of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). There is neither a dietary reference intake (DRI) nor FDA-approved health claim that accurately reflects the current state of the science.
Takeaways for Your Business
The lack of a DRI for long-chain omega-3s may be hindering claim approval in the United States.
The EU has authorized numerous claims (nutrition and health) related to omega-3 fatty acids.
In Japan, foods with function claims cant market products to populations such as expectant mothers.
Nutegrity brings together the expertise of Cyvex Nutrition (botanicals and fish oils), Wisconsin Specialty Protein (dairy ingredients) and InCon Processing (molecular distillation), all subsidiaries of Omega Protein Corporation, to meet the evolving needs of todays health-conscious consumer.
Nutegritys mission is to provide pure, sustainable human nutrition products that support healthy living including a wide range of marine-based omega-3s/EFAs, dairy and plant protein products, specialty dairy ingredients, and botanically sourced ingredients for use in functional food and beverage applications.
You May Also Like